Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells

Histopathology

Volumn 37, Issue 5, 2000, Pages 420-426

  Van Spronsen, D J ^a   Peh, S C ^c   Vrints, L W ^b   Van Imhoff, G W ^a   Poppema, S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Apoptosis; Bcl 2; Hodgkin's lymphoma; Multidrug resistance; Prognosis; Proliferation index

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BAX; PROTEIN BCL 2;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGISTRY; CANCER REGRESSION; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; TISSUE SECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, NUCLEAR; BCL-2-ASSOCIATED X PROTEIN; CELL COUNT; DRUG RESISTANCE, NEOPLASM; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOCYTES; MALE; NEOPLASM STAGING; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REED-STERNBERG CELLS; REMISSION INDUCTION; SCLEROSIS; SURVIVAL RATE;

EID: 0033731125     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.01010.x     Document Type: Article

References (26)

1. Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's lymphoma for unselected patients, 1972-92
2. Classical Hodgkin's lymphoma: Clinical impact of the immunophenotype
3. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
4. Hodgkin cells accumulate mRNA for Bcl-2
5. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: An analysis of 83 cases
6. Prognostic significance of Bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
7. Prognostic significance of Bcl-2 expression and bcl-2 major breakpoint rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation study
8. Clinical significance of Bcl-2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study
9. Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas
10. Bcl-2 expression correlates with lower proliferative activity in the intermediate- and highgrade non-Hodgkin's lymphomas: An eastern cooperative oncology group and southwest oncology group cooperative laboratory study
11. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma
12. Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's lymphoma
13. Induction of bcl-2 expression by Epstein-bar virus latent membrane protein 1 protects infected B cells from programmed cell death
14. Mitotic activity and nuclear DNA damage of Large cells in Hodgkin's lymphoma: Comparison with the expression of p53 and bcl-2 proteins and the presence of Epstein-Barr virus
15. Epstein-Barr virus infection and bcl-2 proto-oncogen expression: Separate events in the pathogenesis of Hodgkin's lymphoma
16. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells
17. The (14; 18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease
18. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or c-erb B-2 proteins on Reed-Sternberg cells: Prognostic significance in Hodgkin's lymphoma
19. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's lymphoma: Involvement of apoptosis resistance?
20. Improved survival of Hodgkin's patients in Southeast Netherlands since 1972
21. Effects of antigen retrieval by microwave heating in formalin-fixed tissue sections on a broad panel of antibodies
22. The relationship between Bcl-2 expression and response to chemotherapy in acute leukemia
23. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance
24. Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death
25. Modest decline in late mortality following Hodgkin's lymphoma in the southeastern Netherlands since 1972
26. A prognostic score for advanced Hodgkin's disease